Skip to main content
Premium Trial:

Request an Annual Quote

GLS, Michigan High Throughput Screening Center to Offer Cellular Screening Services

NEW YORK (GenomeWeb News) - Global Lifescience Solutions, a segment of non-profit safety testing firm NSF International, said this week that it will partner with the Michigan High Throughput Screening Center in Kalamazoo, Mich., to offer screening services that may help companies identify potential leads for drug discovery.
 
Through the partnership, MHTSC will add high-content screening services from GLS to its current menu of high-throughput screening services.
 
MHTSC, a non-profit located at Kalamazoo Valley Community College, will now provide prescreening services, assay development, development and optimization services, follow-up screening services, and will help companies examine multiple cellular targets and parameters in individually imaged cells. MHTSC does not charge licensing or royalty fees.
 
"As more and more drug companies outsource their research and testing, our goal is to provide solutions that will expedite the drug development process," said Aline Lindbeck, general manager of the Ann Arbor-based GLS.
 
GLS said it expects MHTSC to offer pre-screening services to biotechnology companies, government institutions, and to pharmaceutical companies that do not have in-house screening available.
 
Financial terms of the agreement were not released.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.